CANCER GENETICS, INC·4

Jul 13, 4:28 PM ET

CANCER GENETICS, INC 4

4 · CANCER GENETICS, INC · Filed Jul 13, 2016

Insider Transaction Report

Form 4
Period: 2016-07-11
ROBERTS JOHN A
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-07-11+120,000120,000 total
    Exercise: $2.04Exp: 2026-07-11Common Stock, par value $0.0001 per share (120,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest as follows: 2,500 options vesting on the date of grant and the remaining 117,500 options vesting in equal monthly installments of 2,500 shares commencing one month following the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period.

Documents

1 file
  • 4
    wf-form4_146844170036530.xmlPrimary

    FORM 4